IMPORTANCE Bilateral vocal fold immobility (BVFI) can result in considerable voice and airway impairment. Although the carbon dioxide (CO 2 ) laser is commonly used in transverse cordotomy, the coblator, a minimally invasive, low-thermal technology, has been increasingly used in otolaryngology.
B
ilateral vocal fold immobility (BVFI) presents a challenging problem to the otolaryngologist. It is a potentially fatal condition that requires prompt and accurate diagnosis. The goal of treating patients with BVFI is to establish a patent airway, preserve the function of the glottic sphincter, and maintain acceptable voice quality if possible. 1 Surgical intervention is critical in patients with symptomatic airway compromise. 2 The etiology of BVFI includes intubation trauma to the cricoarytenoid joints or posterior commissure, peripheral nerve injury from either neoplasm or surgery, and neuromuscular diseases. 3 Bilateral vocal fold immobility rarely occurs in the absence of a clear cause. 3 Complete evaluation prior to surgical intervention is important to establish the etiology, determine the chronicity of the bilateral motion impairment, and portend the likelihood of spontaneous recovery. Various procedures can be performed to treat BVFI. For iatrogenic injury where there is a possibility of spontaneous recovery, tracheostomy is well accepted and appropriate. Endoscopic suture lateralization is another option for appropriately selected patients. 4 When recovery of vocal cord motion is unlikely or impossible, more ablative procedures such as vocal cordotomy with or without medial partial arytenoidectomy to enlarge the glottic airway may be pursued. Current endoscopic techniques typically employ laser technology to perform the cordotomy and ablate the medial aspect of the arytenoid to some degree. 3 These procedures are often well tolerated and seek to strike a balance between enlarging the airway and preserving voice. Laser usage can be an effective tool for these procedures but intraoperative bleeding can sometimes be encountered and postoperative granulation tissue and collateral heat injury is possible. 5 There is an opportunity for using technology that shortens surgical time and limits heat-related collateral soft tissue injury. The first coblation tonsillectomy was performed in the late 1990s. 6 Since that time, the coblator has been increasingly used in the field of otolaryngology. 7 The coblator uses radiofrequency energy through a saline medium to create a plasma that breaks molecular bonds in the tissue, causing the tissue to dissolve at relatively low temperatures. 8 We describe the utility and outcomes of coblation for vocal cordotomy and partial arytenoidectomy for patients with BVFI. We sought to use this approach to perform vocal cordotomy to treat BVFI with the COBLATOR II Arthrocare via a direct microlaryngoscopic approach. We hypothesized that coblation would be an effective and efficient method to treat BVFI.
Methods

Patient Selection
Institutional review board approval was obtained prior to study initiation. A consecutive retrospective review of all patients with BVFI undergoing vocal cordotomy by coblation at a single tertiary care institution between January 2012 and June 2017 was conducted. Patients requiring the use of a KTP laser to assist with complete ablation of arytenoid cartilage and those under 18 years were excluded.
If the patient had a prior tracheotomy, general anesthesia was induced and the tracheostoma was used for ventilation. In the remaining patients who did not have a tracheostomy, the procedure was completed via supraglottic jet ventilation or intermittent apnea. The Pilling-Teleflex Dedo laryngoscope or Universal Modular Glottiscope (Endocraft, LLC) were the most commonly used laryngoscopes. The coblator PROCISE LW laryngeal wand (Smith & Nephew) was used on a power setting of 7 for coblation. Lidocaine was applied to the vocal folds and the patient was then either intubated or mask ventilated by the anesthesia team. No patients required a tracheotomy with this procedure.
Data Collection
Demographic, medical history, operative, and health status measure (HSM) data were retrospectively collected from electronic medical records. Preoperative data included sex, Health status measure data, such as the EuroQol-5 Dimension (EQ-5D) and Voice Handicap Index (VHI) were collected both prior to and following surgery. The EQ-5D is a quality of life (QOL) measure that includes 5 dimensions of a patient's health state: mobility, self-care, completion of usual activities, pain/discomfort, and anxiety/depression. Each is scored on a scale from 1 to 3, and an index is derived from the 5 subscores to represent the patient's overall health state ranging from 0 to 1. [9] [10] [11] The MCID for the EQ-5D index has been reported to be 0.1. 12 The VHI is a validated self-administered questionnaire that assesses the functional, emotional, and psychosocial consequences of voice disorders. [13] [14] [15] A difference in 13 to 16 points in the VHI has been proposed to be clinically meaningful, although it remains unclear what specific changes in the subsections of the VHI are clinically meaningful. 16 Charge data were extracted using the institution's financial utilization engine. These data were generated based on patient-level resource utilization and include the total cost of delivering care in the outpatient and inpatient settings across the health system. Charges were collected from 365 days prior to admission to 365 days after admission and subdivided into 30-, 90-, and 365-day preadmission and postadmission windows. Relevant charges were defined as any preadmission or postadmission health care costs associated with treating BVFI. To present costs from the payer's perspective, bills were normalized to national Medicare reimbursement rates based on cost-to-charge ratios and presented as 2017 dollars.
17,18
Statistical Analyses
All collected data were analyzed using R statistical software (version 3.4.0, R Foundation for Statistical Computing). 19 Descriptive statistics for quantitative variables were presented as means with 95% confidence intervals (95% CI) or medians with interquartile ranges, while categorical variables were presented as counts with percentages. Effect sizes were reported with corresponding 95% CI to represent differences between preoperative and postoperative measures. 16 
Results
Patient and Operative Characteristics
A total of 19 patients underwent vocal cordotomy by coblation during the study period, 4 of which had posterior glottic stenosis in addition to BVFI ( Table 1) . Thirteen (68%) patients were women with a mean age of 56 years. Seventeen (89%) patients were white. Ten (53%) patients had no smoking history, whereas all but 1 (42%) of the remaining patients were former smokers. The mean BMI was 28.3. The etiology of BVFI included postthyroidectomy in 8 (42%) patients, prolonged intubation and/or trauma in 7 (37%), idiopathic in 2 (11%), cancer in 1 (5%), and pneumonia in 1 (5%). Prior to surgery, 26% of patients had a tracheostomy, and 26% of patients had undergone prior cordotomy. Images of the vocal folds prior to and after a coblation cordotomy are noted in the Figure. The 15 patients who received cordotomy by coblation to treat BVFI without stenosis and without the use of a laser were included for subsequent analyses. Among these patients, the cordotomy was performed with limited partial arytenoidec- tomy with the removal of the vocal process of the arytenoid in 7 (47%) of 15 patients ( Table 2 ). The mean procedure time was 17 minutes, defined as the time elapsed between the insertion and removal of the laryngoscope. The actual time for the coblation portion of the cordotomy operation ranged from 20 to 60 seconds and in some cases was completed with the patient apneic. In addition, the mean total OR time necessary was approximately 1 hour, considerably less than the mean scheduled OR time (63 vs 88 minutes; effect size, 25 minutes; 95% CI, 9 to 40 minutes), whereas scheduled OR time is the average OR time for cordotomy based on historical OR times at our institution. These 15 patients who underwent cordotomy by coblation for BVFI without glottic stenosis or use of a laser were followed postoperatively for a mean of 516 days. During follow-up, 4 patients (27%) developed granulation tissue; half of these instances resolved without treatment, whereas 1 patient received medical treatment and the other underwent surgical excision. Compared with patients in whom the carbon dioxide (CO 2 ) laser was used, patients who underwent cordotomy by coblation seemed to have less prolonged healing with improved glottic airway. However, owing to variable follow-up times, it was infeasible to quantitatively assess healing times. Among those patients with a tracheostomy prior to surgery, 3 (60%) of 5 patients were successfully decannulated following surgery. Seven (47%) of 15 patients underwent at least 1 subsequent revision surgery to treat BVFI. This is consistent with our philosophy of static procedures for BVFI, where we err on being conservative to limit permanent impact on the voice.
Patient-reported shortness of breath was recorded before and after surgery as no limitations, exercise intolerance, or daily limitations. Prior to surgery, 6 (40%) patients expressed daily limitations and 8 (53%) patients experienced exercise intolerance ( Table 3) . Patients experienced considerable improvement in their breathing after coblation-only 1 (7%) patient expressed daily limitations and 7 (47%) patients expressed exercise intolerance following surgery. Among the 14 patients with some level of preoperative difficulty breathing, 10 (71%) patients experienced improvement (95% CI, 45% to 88%). Stridor was also recorded on 3 levels as none, mild, and severe. Patients demonstrated similar improvement with regard to stridor; whereas 3 (20%) patients had severe stridor and 9 (60%) patients had mild stridor prior to surgery, only 4 (27%) patients had mild stridor after coblation with the remaining 11 (73%) patients demonstrating no stridor. Among the 12 patients with some level of preoperative stridor, 10 (83%) patients experienced improvement (95% CI, 55% to 95%). Patient QOL measured by the EQ-5D index increased from a mean of 0.67 preoperatively to 0.80 postoperatively. The mean absolute difference for the group was 0. Vocal cordotomy by coblation also appeared to be a costeffective method to treat BVFI ( Table 4) . Prior to the operation, the median total costs of medical care were $1272, $2471, and $2471 for the 30-, 90-, and 365-day preoperative time periods, respectively, nearly all of which were in the outpatient setting and for the purposes of treating BVFI. These costs remained low and tended to decrease following surgery. The median total costs of medical care were $0, $939, and $1693 in the 30-, 90-, and 365-day day postoperative time periods, respectively, again largely in the outpatient setting and for the treatment of BVFI.
Discussion
Coblation has become an increasingly useful tool for otolaryngologists in recent years. In addition to its frequent use for tonsillectomies, coblation has been used for the removal of laryngeal Teflon granulomas, 8 treatment of recurrent respiratory papillomatosis, 20 and removal of suprastomal tracheal granulomas, neurofibromas, and arteriovenous malformations. 21 In each case, coblation has been demonstrated to be an acceptable alternative to the CO 2 laser. The coblator device tip uses radiofrequency energy through a saline medium to create a plasma. The plasma's energized particles break molecular bonds in the tissue, causing the tissue to dissolve at relatively low temperatures. 8 This helps to avert considerable lateral heat distribution into the tissue, while also reducing the risk of airway fire. 20 We describe the utility and outcomes of coblation for vocal cordotomy and partial arytenoidectomy for BVFI.
At present, the CO 2 laser is the mainstay method for performing cordotomy. [22] [23] [24] Although this is generally a safe and effective approach for restoring the airway and providing patients with benefits, such as improved exercise tolerance, there are numerous adverse effects associated with use of the laser. Owing to the higher temperatures generated by the laser, these patients tend to more often develop granulation tissue requiring subsequent excision. Furthermore, patients more often suffered from postoperative vocal edema requiring either oral corticosteroids or tracheotomy. Last, it remains unclear whether cordotomy using the CO 2 laser provides any significant patient benefit with regard to vocal fold function. There are many advantages to using the coblator over the CO 2 laser. For instance, no laser protection is required with the coblator, thus helping to reduce operative set-up and procedure time. This increased efficiency in the OR is Although the actual time required to perform the cordotomy once the patient is in suspension laryngoscopy is difficult to measure, coblation requires a brief period for completion, typically 20 to 60 seconds. It can also be done with the use of a microscope or a rigid telescope. The coblation hand piece also offers the surgeon the ability to work tangentially, with less need to adjust the microscope as one might for a CO 2 laser mounted on a micromanipulator or pattern generator. The coblation wand also offers bipolar cautery that may be useful if bleeding is encountered. The ability to perform the procedure rapidly and often with the patient apneic is appealing. In our group, no patient who did not have a tracheostomy required one to do the procedure. The patients included in this case series consistently showed improvement in the glottic airway immediately following the procedure and during follow-up. Based on the extensive experience of the authors using the CO 2 laser for cordotomies, healing time also appeared to be expedited compared with procedures using the CO 2 laser. These improvements following surgery are especially notable given the observed improvements in patient breathing, stridor, and HSM during follow-up. In particular, most patients experienced significant improvements in both their shortness of breath symptoms (71%) and stridor (83%). Furthermore, the mean absolute difference in the EQ-5D index was 0.13 with 9 of 15 patients improving by more than the established MCID of 0.1, 12 suggesting that patients undergoing cordotomy by coblation for BVFI can experience a clinically meaningful improvement in overall QOL. Furthermore, the average improvement in the VHI (29 points) was both statistically significant and nearly double the range of 13 to 16 points considered to be clinically meaningful, 16 suggesting that cordotomy by coblation for BVFI is especially successful at providing patients with clinically meaningful improvement in their vocal fold functioning. Thus, coblation appears to be an efficient and effective substitute for the CO 2 laser for performing vocal cordotomy.
Limitations
The present study includes several limitations. As a retrospective study, the collected data reported by clinicians were not standardized, potentially subjecting our results to measurement bias, although the senior author has used this device exclusively for his lateralization procedures for BVFI without stenosis for the past 3 years. In particular, our scales for measuring shortness of breath and stridor have not been previously validated; however, we believe that these allow for detection of important trends with even a single-level improvement representing clinically meaningful benefit. Similarly, although the differences in 13 to 16 points in the total VHI are believed to be clinically meaningful, it remains unclear what level of change in the individual components of the VHI are clinically meaningful. Our results are also subject to selection bias because clinicians may have chosen to use coblation in a certain subset of patients more likely to benefit from coblation over the CO 2 laser, thus limiting the generalizability of these results. This may be true with regard to avoiding tracheostomy. Although we do not plan a tracheotomy for patients who are functioning with BVFI without a tracheostomy, we recognize that patient factors and comorbidities may make performing a tracheostomy prior to cordotomy and/or partial arytenoidectomy a safer choice regardless of the ablative technology used to perform the glottic widening procedure.
Conclusions
To our knowledge, the present study is the first to investigate outcomes associated with the use of coblation to perform vocal cordotomy in the treatment of BVFI. Initial outcomes of cordotomy by coblation reveal this technique to be a safe, efficient, and effective approach to treating BVFI. Coblation required very short operative times and considerably reduced the total operating room time requirement. In addition, patient-reported shortness of breath, stridor on examination, and vocal cord function improved significantly over follow-up. Coblation is a useful addition to the surgeon's armamentarium for endoscopic airway surgery.
